Growth differentiation factor receptors, and methods of using same

The present invention provides an activin type IIB receptor (ActRIIB) for use in the treatment or prevention of a muscle disease or disorder in a mammal. The muscle disease or disorder may be muscular dystrophy, muscle atrophy or a muscle wasting disorder.

Patents:
EP 2,322,199

Inventor(s): LEE SIN-JIN [US]; MCPHERRON ALEXANDRA C [US]

Type of Offer: Licensing